A day before Covid vaccine booster shots become available to all Indian adults, the prices of Covishield and Covaxin at private hospitals have been slashed by more than half. Both the vaccine doses will now cost Rs 225. While Covishield has been slashed from Rs 600, Covaxin is down from Rs 1,200 per dose. Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella made the announcement on Twitter today. The decision was taken after discussions with the Centre. Mr Poonawala had told NDTV yesterday that Covishield will cost Rs 600 plus taxes (same as before).
"We are pleased to announce that after discussion with the Central Government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose. We once again commend this decision from the Centre to open precautionary dose to all 18+," Mr Poonawala tweeted.
"Announcing #CovaxinPricing. We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1200 to Rs 225 per dose, for #privatehospitals," Ms Ella tweeted soon after.
The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
Mr Poonawala had yesterday welcomed the Centre's announcement. Calling it a crucial and timely decision, he said people who wished to travel were finding it difficult to do so without a third dose as several countries have placed restrictions on those who have not taken a booster dose.
"Ongoing free vaccination programme through government vaccination centres for first and second dose as well as Precaution Dose to Healthcare Workers, Frontline Workers and 60+ population would continue and would be accelerated," a government statement yesterday said.
About 96 per cent of the 15 and above population in the country have received at least one COVID-19 vaccine dose while about 83 per cent of has received both doses, it added.
More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers and those aged above 60 years. Besides, 45 per cent of beneficiaries in the 12-14 years age group have received the first dose, the Ministry said.
Justice DY Chandrachud's Final Message As Chief Justice Of India DY Chandrachud's Last Working Day: What Do Chief Justices Do After Term Ends Aligarh Muslim University A Minority Institution? Supreme Court's Key 4:3 Verdict Watch Out For These Health Issues As The Days Get Colder Poll Bonds To Article 370: 10 Key Judgments By Chief Justice DY Chandrachud Karnataka Hikes Incentives For SC, ST Students In Premier Institutes Track Latest News Live on NDTV.com and get news updates from India and around the world.